Spontaneous bacterial peritonitis caused by Brucella melitensis

Scandinavian Journal of Infectious Diseases

Volumn 35, Issue 5, 2003, Pages 341-343

  Gençer, Serap ^a   Özer, Serdar ^a  

^a Kartal Dr L Kirdar Train/Res Hosp ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; FUROSEMIDE; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SPIRONOLACTONE; STREPTOMYCIN; SULPERAZON; TETRACYCLINE;

AGED; AGGLUTINATION TEST; ARTICLE; ASCITES; ASCITES FLUID; BACTERIAL PERITONITIS; BLOOD CULTURE; BRUCELLA MELITENSIS; CASE REPORT; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; ECHOGRAPHY; HUMAN; MALE; PARACENTESIS; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANTI-BACTERIAL AGENTS; ASCITIC FLUID; BRUCELLA MELITENSIS; BRUCELLOSIS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; MALE; PERITONITIS; RISK ASSESSMENT; TREATMENT OUTCOME; TURKEY;

EID: 0038793420     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310000238     Document Type: Article

References (17)

1. Young EJ. Brucella species. In: Mandell GL, Bennett Je, Dolin R, eds. Principles and practice of infectious diseases, 5th edn. Philadelphia, PA: Churchill Livingstone, 2000. p. 2386-93.
2. Aygen B, Doganay M, Sümerkan B, Yildiz O, Kayabas Ü. Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients. Méd Mal Infect 2002; 32: 485-93.
3. Young EJ. An overview of human brucellosis. Clin Infect Dis 1995; 21: 283-90.
4. Ariza J. Brucellosis. Curr Opin Infect Dis 1996; 9: 126-31.
5. Cabellaria E, Masso RM, Arago JV, Sanchis A. Ascites as the first manifestation of Brucella granulomatous hepatitis. J Hepatol 1992; 15: 415-6.
6. Williams RK, Crossley K. Acute and chronic hepatic involvement of brucellosis. Gastroenterology 1982; 83: 455-8.
7. Diab SM, Araj GF, Al-Asfour AJ, Al-Yusuf AR. Brucellosis: a typical presentation with peritonitis and meningitis. Trop Geogr Med 1989; 41: 160-3.
8. Al-Mudallal DS, Mousa AR, Marafie AA. Apyrexic Brucella melitensis aortic valve endocarditis. Trop Geogr Med 1989; 41: 372-6.
9. Andersen H, Mortensen A. Unrecognised neurobrucellosis giving rise to Brucella melitensis peritonitis via a ventriculoperitoneal shunt. Eur J Clin Microbiol Infect Dis 1992; 11: 953-4.
10. Demirkan F, Akalin HE, Simsek H, Özyilkan E, Telatar H. Spontaneous peritonitis due to Brucella melitensis in a patient with cirrhosis. Eur J Clin Microbiol Infect Dis 1993; 12: 66-7.
11. Doganay M, Aygen B, Inan M, Ozbakir O. Brucella peritonitis in a cirrhotic patient with ascites. Eur J Med 1993; 2: 441-2.
12. Halim MA, Ayub A, Abdulkareem A, Ellis ME, Al-Gazlan S. Brucella peritonitis. J Infect 1993; 27: 169-72.
13. Locutara J, Lorenzo JF, Mijan A, Galdos-Barroso M, Saez-Royuela F. Non-simultaneous Brucella peritonitis and meningitis in a patient with a ventriculoperitoneal shunt. Eur J Clin Microbiol Infect Dis 1998; 17: 361-8.
14. Özakyol AH, Sariçam T, Zubaroglu I. Spontaneous bacterial peritonitis due to Brucella melitensis in a cirrhotic patient. Am J Gastroenterol 1999; 94: 2572-3.
15. Alcala L, Munoz P, Rodriguez-Creixems M, Banares R, Bouza E. Brucella spp. peritonitis. Am J Med 1999; 107: 300.
16. Taskapan H, Oymak O, Sumerkan B, Tokgoz B, Utas C. Brucella peritonitis in a patient on continuous ambulatory peritoneal dialysis with acute brucellosis. Nephron 2002; 91: 156-8.
17. Akova M, Uzun Ö, Akalin HE, Hayran M, Ünal S, Gür D. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin. Antimicrob Agents Chemother 1993; 37: 1831-4.